scispace - formally typeset
E

Emily Kim

Researcher at Harvard University

Publications -  25
Citations -  3527

Emily Kim is an academic researcher from Harvard University. The author has contributed to research in topics: GTPase-activating protein & RGS Proteins. The author has an hindex of 19, co-authored 25 publications receiving 3395 citations. Previous affiliations of Emily Kim include University of Freiburg & Beth Israel Deaconess Medical Center.

Papers
More filters
Journal ArticleDOI

RIP : a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death

TL;DR: Transient overexpression of RIP causes transfected cells to undergo the morphological changes characteristic of apoptosis, and these properties indicate that RIP is a novel form of apoptotic-inducing protein.
Journal ArticleDOI

Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2.

TL;DR: In this paper, the C-terminal cytoplasmic tails of PKD1 and PKD2 were found to form homodimers through a coiled-coil domain distinct from the region required for interaction with PKD 1.
Journal ArticleDOI

Specific association of the gene product of PKD2 with the TRPC1 channel

TL;DR: In this paper, sequence homology between PKD2 and various members of the mammalian transient receptor potential channel (TRPC) proteins, thought to be activated by G protein-coupled receptor activation and/or depletion of internal Ca2+ stores, was described.
Journal ArticleDOI

The Polycystic Kidney Disease 1 Gene Product Modulates Wnt Signaling

TL;DR: It is reported here that expression of the C-terminal cytoplasmic domain of polycystin stabilizes soluble endogenous β-catenin and stimulates TCF-dependent gene transcription in human embryonic kidney cells, and suggest that poly Cystin has the capacity to modulate Wnt signaling during renal development.